Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I3 | Q14994 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.62 |
| ▸ | SHBG | P04278 | 1/20 | 0.62 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | GABRP | O00591 | 1/20 | 0.55 |
| ▸ | GABRD | O14764 | 1/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Androstenol SCHEMBL3163766 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL324888 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL8817019 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL5072488 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL9543417 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL8817023 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL3163769 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL4533664 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL14360552 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL27501533 | 0.88 | KDM4E (0.81) | NR1I3ALDH1A1LMNAGPBAR1SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108289898-A | In the pheromone compositions and its application method of female pigs category animal moderate stimulation reproduction | 德克萨斯理工大学系统 | 2018-07-17 | — | — | CN | claimed |
| EP-0139554-B1 | DERIVATIVES OF MURAMYL PEPTIDES AND STEROIDS HAVING MACROPHAGE ACTIVATING PROPERTIES | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1989-08-02 | — | — | EP | claimed |
| US-4663311-A | Derivatives of muramyl-peptides and of steroids having macrophage-activating properties | TENU JEAN P (FR) | 1987-05-05 | — | — | US | claimed |
| US-20240336711-A1 | REAGENTS AND METHODS FOR ALIPHATIC CARBON-HYDROGEN BOND FUNCTIONALIZATION | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2024-10-10 | — | — | US | disclosed |
| WO-2022241129-A1 | REAGENTS AND METHODS FOR ALIPHATIC CARBON—HYDROGEN BOND FUNCTIONALIZATION | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-11-17 | — | — | WO | disclosed |
| CN-110604754-B | Pheromone composition capable of improving estrus mating rate of sows | 宁波第二激素厂 | 2021-11-26 | — | — | CN | disclosed |
| CN-110664862-B | Pheromone composition spray preparation and preparation method and application thereof | 宁波第二激素厂 | 2021-07-30 | — | — | CN | disclosed |
| US-10908162-B2 | Methods related to volatile compounds in genitourinary cancers | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-02-02 | — | — | US | disclosed |
| CN-110664862-A | Pheromone composition spray preparation and preparation method and application thereof | 宁波第二激素厂 | 2020-01-10 | — | — | CN | disclosed |
| CN-110604754-A | Pheromone composition capable of improving estrus mating rate of sows | 宁波第二激素厂 | 2019-12-24 | — | — | CN | disclosed |
| US-20190128890-A1 | METHODS RELATED TO VOLATILE COMPOUNDS IN GENITOURINARY CANCERS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-05-02 | — | — | US | disclosed |
| EP-0209578-A1 | METHOD USING POOLED FEMALE AXILLARY ESSENCE FROM MULTIPLE DONORS TO ALTER MENSTRUAL CYCLE TIMING | MONELL CHEMICAL SENSES CENTER (US) | 1987-01-28 | — | — | EP | disclosed |
| EP-0084537-B1 | METHOD AND MEANS FOR REPELLING ANIMALS | NORDTEND A/S (NO) | 1986-10-15 | — | — | EP | disclosed |
| WO-1986004238-A1 | METHOD USING POOLED FEMALE AXILLARY ESSENCE FROM MULTIPLE DONORS TO ALTER MENSTRUAL CYCLE TIMING | MONELL CHEMICAL SENSES CENTER (US) | 1986-07-31 | — | — | WO | disclosed |
| WO-1986004418-A1 | AXILLARY ANDROSTENOL AND DEHYDROEPIANDROSTERONE AS FERTILE PERIOD ONSET INDICATORS | MONELL CHEMICAL SENSES CENTER (US) | 1986-07-31 | — | — | WO | disclosed |
| WO-1986004236-A1 | THE USE OF MALE ESSENCE, INCLUDING ANDROSTENOL AND DEHYDROEPIANDROSTERONE SULFATE TO TREAT LUTEAL PHASE DEFECTS AND FAILURE TO OVULATE IN HUMAN FEMALES | MONELL CHEMICAL SENSES CENTER (US) | 1986-07-31 | — | — | WO | disclosed |
| EP-0139554-A1 | Derivatives of muramyl peptides and steroids having macrophage activating properties | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1985-05-02 | — | — | EP | disclosed |
| US-4451460-A | WITH HUMAN STEROIDS | NORDTEND A/S (NO) | 1984-05-29 | — | — | US | disclosed |
| EP-0084537-A1 | METHOD AND MEANS FOR REPELLING ANIMALS. | NORDTEND AS (NO) | 1983-08-03 | — | — | EP | disclosed |
| WO-1983000417-A1 | METHOD AND MEANS FOR REPELLING ANIMALS | HANSEN, HELGE | 1983-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336711-A1 | REAGENTS AND METHODS FOR ALIPHATIC CARBON-HYDROGEN BOND FUNCTIONALIZATION | NCF1, SHROOM3, NPM1 | NR1I3 4045/4885ALDH1A1 2010/4885LMNA 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.